1. Home
  2. LIQT vs MRKR Comparison

LIQT vs MRKR Comparison

Compare LIQT & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiqTech International Inc.

LIQT

LiqTech International Inc.

HOLD

Current Price

$1.88

Market Cap

19.3M

Sector

Technology

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.45

Market Cap

16.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIQT
MRKR
Founded
2004
N/A
Country
Denmark
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.3M
16.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LIQT
MRKR
Price
$1.88
$1.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$4.20
$10.17
AVG Volume (30 Days)
16.3K
330.4K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,788,295.00
$4,694,988.00
Revenue This Year
$34.09
N/A
Revenue Next Year
$18.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.97
N/A
52 Week Low
$1.34
$0.81
52 Week High
$3.35
$5.95

Technical Indicators

Market Signals
Indicator
LIQT
MRKR
Relative Strength Index (RSI) 40.45 67.32
Support Level $1.81 $1.40
Resistance Level $2.14 $1.49
Average True Range (ATR) 0.11 0.10
MACD 0.01 0.03
Stochastic Oscillator 2.47 95.45

Price Performance

Historical Comparison
LIQT
MRKR

About LIQT LiqTech International Inc.

LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: